Clinical Trial Update: Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis [Phase 2]

View source ↗

Summary

Phase 2 open-label dose-finding trial of OPC-41061 in patients with chronic kidney disease undergoing peritoneal dialysis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• OPC-41061

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure | Phase 2 | Status: COMPLETED | Results posted: 2016-01-01